Samuel U. Takvorian

Dr. Samuel U. Takvorian is an Assistant Professor of Medicine specializing in Hematology-Oncology at the University of Pennsylvania's Perelman School of Medicine. He is a physician at Penn Medicine with clinical appointments at the Abramson Cancer Center, seeing patients at both the Philadelphia and Radnor locations. Dr. Takvorian holds hospital privileges at the Hospital of the University of Pennsylvania and maintains an exceptional patient satisfaction rating of 5.0 based on 662 reviews.

Dr. Takvorian's research spans multiple critical areas in oncology with a particular focus on prostate cancer, geriatric oncology, and innovative cancer treatment approaches. His work examines the safety of combining external beam radiotherapy with 177Lu-PSMA-617 for metastatic prostate cancer, implementation strategies for geriatric assessments in community cancer practices, and cardiovascular complications from prostate cancer treatments. He is actively involved in implementation science research through the Penn Implementation Science Center in Cancer Control.

His recent publication record (2024-2025) demonstrates significant research productivity across diverse oncology topics including prostate cancer genetics, geriatric dosing strategies, psycho-oncology, and digital health tools in cancer care. These publications appear in high-impact journals such as The Journal of Nuclear Medicine, Journal of Geriatric Oncology, and Clinical Genitourinary Cancer, reflecting his contributions to advancing cancer treatment and care delivery.

Dr. Takvorian completed his medical education at Harvard Medical School, followed by residency at Massachusetts General Hospital/Brigham and Women's Hospital, and fellowship training at the Hospital of the University of Pennsylvania. His clinical expertise encompasses treating a wide range of cancer conditions with particular emphasis on prostate cancer and geriatric oncology, where he applies evidence-based approaches to optimize treatment for older and vulnerable patients.

As part of the Abramson Cancer Center, Dr. Takvorian collaborates with multidisciplinary teams to provide comprehensive cancer care while advancing research that addresses critical gaps in prostate cancer treatment, geriatric oncology, and implementation of innovative care models in community practice settings.